Pharmacological Inhibition of MMP3 as a Potential Therapeutic Option for COVID-19 Associated Acute Respiratory Distress SyndromeCOVID-19 관련 급성 호흡 곤란 증후군에 대한 잠재적인 치료 옵션으로서 MMP3의 약리학적 억제Article Published on 2021-01-012022-09-11 Journal: Infectious disorders drug targets [Category] MERS, 바이오마커, 치료기술, 치료제, [키워드] acute respiratory distress acute respiratory distress syndrome ARDS ARDS patient ARDS patients bacterial lipopolysaccharide Biomarker coronavirus disease Coronavirus disease 2019 COVID-19 COVID-19 patient COVID-19 patients Early detection elevated high mortality inhibition Laboratory lipopolysaccharide matrix mediator mice MMP3 molecular mechanism molecular mechanisms option organ Patient plasma Potential Previous studies previous study progression reduce reduce mortality reported respiratory respiratory distress Respiratory distress syndrome severity stromelysin1 switch syndrome therapeutic treat virus infection [DOI] 10.2174/1871526520666201116100310 PMC 바로가기 [Article Type] Article